Designation places Mount Sinai among top one percent of cancer centers nationwide Mount Sinai Tisch Cancer Hospital Mount ...
Factors Likely to Influence INCY's Q3 Results. Incyte primarily derives product revenues from the sales of its ...
Geron Corporation has strong RYTELO sales, robust financials, and global growth plans. Click here to read an analysis of GERN ...
Patanjali doctors in Haridwar reported a rare blood cancer recovery using only Ayurvedic medicines, showcasing Ayurveda’s ...
Bristol-Myers Squibb Company has had a recent 30% stock decline amid concerns over patent expirations. Click here to read why BMY stock is a Hold.
Incyte INCY has put up a stellar performance year to date on the back of better-than-expected quarterly results, and positive ...
Detailed price information for Karyopharm Therapeut (KPTI-Q) from The Globe and Mail including charting and trades.
A new study by investigators at Dana-Farber Cancer Institute and Harvard Medical School is providing one of the most detailed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback